Mohube Betty Maepa

Publications

29

Citations

542

h-index

11

Publishing journals

22

Years of publications

17

Active since

2009

References

2.4K

Institutions

5

1. Long-term inhibition of Hepatitis B virus gene expression by a primary microrna expressing ancestral adeno-associated viral vector
   Virology Journal, Volume 22, Issue 1, Pages 41-41, Year 2025
2. Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic Mice.
   Viruses, Volume 17, Issue 8, Page 1090, Year 2025
3. Bridging gene therapy and next-generation vaccine technologies
   Gene Therapy, Volume 32, Issue 1, No. eabl9900, Pages 4-7, Year 2025
4. Recent Advances in Designing Adeno-Associated Virus-Based Vaccines Against Viral Infections
   Pharmaceutics, Volume 16, Issue 11, No. 1360, Page 1360, Year 2024
5. Situational Division and the Dynamics of Rural Health Care of Blacks in the Former Transvaal Province of South Africa During Apartheid Era, 1948-1980s
   American Journal of Biomedical Science & Research, Volume 25, Issue 1, Pages 6-11, Year 2024
6. AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy
   Microorganisms, Volume 11, Issue 12, No. 2985, Page 2985, Year 2023
7. Hepatitis B Virus Research in South Africa
   Viruses, Volume 14, Issue 9, No. 1939, Pages 1939-1939, Year 2022
8. Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics
   Genes, Volume 13, Issue 11, No. 1941, Pages 1941-1941, Year 2022
9. Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases
   Gene Therapy, Volume 32, Issue 1, Pages 8-15, Year 2022
10. Hepatitis B virus: promising drug targets and therapeutic implications
    Expert Opinion on Therapeutic Targets, Volume 25, Issue 6, Pages 451-466, Year 2021
11. Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
    Journal of Hepatocellular Carcinoma, Volume Volume 8, Pages 1-17, Year 2021
12. Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
    Virology Journal, Volume 18, Issue 1, No. 247, Pages 247-247, Year 2021
13. In vivo modelling of hepatitis b virus subgenotype A1 replication using adeno-associated viral vectors
    Viruses, Volume 13, Issue 11, No. 2247, Pages 2247-2247, Year 2021
14. Advances with RNAi-based therapy for hepatitis B virus infection
    Viruses, Volume 12, Issue 8, No. 851, Pages 851-851, Year 2020
15. Recent developments with advancing gene therapy to treat chronic infection with hepatitis B virus
    Current Opinion in HIV and AIDS, Volume 15, Issue 3, Pages 200-207, Year 2020
16. In Vivo Delivery of Cassettes Encoding Anti-HBV Primary MicroRNAs Using an Ancestral Adeno-Associated Viral Vector
    Methods in Molecular Biology, Volume 2115, Pages 171-183, Year 2020
17. Gene and cell therapy in South Africa: Current status and future prospects
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, Volume 109, Issue 8b, Pages 12-16, Year 2019
18. Gene therapy for chronic HBV—Can we eliminate cccDNA?
    Genes, Volume 9, Issue 4, No. 207, Pages 207-207, Year 2018
19. How successful has targeted RNA interference for hepatic fibrosis been?
    Expert Opinion on Biological Therapy, Volume 18, Issue 4, Pages 381-388, Year 2018
20. SsAAVs containing cassettes encoding SaCas9 and guides targeting hepatitis B virus inactivate replication of the virus in cultured cells
    Scientific Reports, Volume 7, Issue 1, No. 7401, Pages 7401-7401, Year 2017

No publications in the index yet.